These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8469335)
1. The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials. Pradas J; Finison L; Andres PL; Thornell B; Hollander D; Munsat TL Neurology; 1993 Apr; 43(4):751-5. PubMed ID: 8469335 [TBL] [Abstract][Full Text] [Related]
2. Can we eliminate placebo in ALS clinical trials? Bryan WW; Hoagland RJ; Murphy J; Armon C; Barohn RJ; Goodpasture JC; Miller RG; Parry GJ; Petajan JH; Ross MA; Stromatt SC; Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):11-5. PubMed ID: 12745612 [TBL] [Abstract][Full Text] [Related]
3. Analysis of health-related quality of life and muscle impairment in individuals with amyotrophic lateral sclerosis using the medical outcome survey and the Tufts Quantitative Neuromuscular Exam. Shields RK; Ruhland JL; Ross MA; Saehler MM; Smith KB; Heffner ML Arch Phys Med Rehabil; 1998 Jul; 79(7):855-62. PubMed ID: 9685105 [TBL] [Abstract][Full Text] [Related]
4. Quantitative motor assessment in amyotrophic lateral sclerosis. Andres PL; Hedlund W; Finison L; Conlon T; Felmus M; Munsat TL Neurology; 1986 Jul; 36(7):937-41. PubMed ID: 3714055 [TBL] [Abstract][Full Text] [Related]
5. Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. SSNJV/CNTF ALS Study Group. McGuire D; Garrison L; Armon C; Barohn R; Bryan W; Miller R; Parry G; Petajan J; Ross M Neurology; 1996 May; 46(5):1442-4. PubMed ID: 8628496 [TBL] [Abstract][Full Text] [Related]
6. Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis. Andres PL; Finison LJ; Conlon T; Thibodeau LM; Munsat TL Neurology; 1988 Mar; 38(3):405-8. PubMed ID: 3347344 [TBL] [Abstract][Full Text] [Related]
7. The natural history of motoneuron loss in amyotrophic lateral sclerosis. Munsat TL; Andres PL; Finison L; Conlon T; Thibodeau L Neurology; 1988 Mar; 38(3):409-13. PubMed ID: 3347345 [TBL] [Abstract][Full Text] [Related]
8. Measurement of isometric muscle strength: a reproducibility study of maximal voluntary contraction in normal subjects and amyotrophic lateral sclerosis patients. Colombo R; Mazzini L; Mora G; Parenzan R; Creola G; Pirali I; Minuco G Med Eng Phys; 2000 Apr; 22(3):167-74. PubMed ID: 10964037 [TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of neuromuscular deficit in ALS. Andres PL; Thibodeau LM; Finison LJ; Munsat TL Neurol Clin; 1987 Feb; 5(1):125-41. PubMed ID: 3550414 [TBL] [Abstract][Full Text] [Related]
10. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063 [TBL] [Abstract][Full Text] [Related]
11. Natural history of amyotrophic lateral sclerosis. Observations with the Charing Cross Amyotrophic Lateral Sclerosis Rating Scales. Guiloff RJ; Goonetilleke A Adv Neurol; 1995; 68():185-98. PubMed ID: 8787229 [TBL] [Abstract][Full Text] [Related]
12. Validation of a new strength measurement device for amyotrophic lateral sclerosis clinical trials. Andres PL; Skerry LM; Munsat TL; Thornell BJ; Szymonifka J; Schoenfeld DA; Cudkowicz ME Muscle Nerve; 2012 Jan; 45(1):81-5. PubMed ID: 22190312 [TBL] [Abstract][Full Text] [Related]
13. Pitfalls in the evaluation of isometric strength (TQNE) data in ALS. Conradi S; Ronnevi LO J Neurol Sci; 1996 Aug; 139 Suppl():60-3. PubMed ID: 8899660 [TBL] [Abstract][Full Text] [Related]
14. Trends of quality of life changes in amyotrophic lateral sclerosis patients. Shamshiri H; Fatehi F; Abolfazli R; Harirchian MH; Sedighi B; Zamani B; Roudbari A; Razazian N; Khamseh F; Nafissi S J Neurol Sci; 2016 Sep; 368():35-40. PubMed ID: 27538598 [TBL] [Abstract][Full Text] [Related]
16. Natural history of muscle cramps in amyotrophic lateral sclerosis. Caress JB; Ciarlone SL; Sullivan EA; Griffin LP; Cartwright MS Muscle Nerve; 2016 Apr; 53(4):513-7. PubMed ID: 26332705 [TBL] [Abstract][Full Text] [Related]
17. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up. Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839 [TBL] [Abstract][Full Text] [Related]
18. Megaslope, natural course, and historical controls in amyotrophic lateral sclerosis trials. Conradi S; Ronnevi LO Adv Neurol; 1995; 68():219-24. PubMed ID: 8787232 [No Abstract] [Full Text] [Related]
19. Natural history of young-adult amyotrophic lateral sclerosis. Sabatelli M; Madia F; Conte A; Luigetti M; Zollino M; Mancuso I; Lo Monaco M; Lippi G; Tonali P Neurology; 2008 Sep; 71(12):876-81. PubMed ID: 18596241 [TBL] [Abstract][Full Text] [Related]
20. Comparison of maximal voluntary isometric contraction and Drachman's hand-held dynamometry in evaluating patients with amyotrophic lateral sclerosis. Beck M; Giess R; Würffel W; Magnus T; Ochs G; Toyka KV Muscle Nerve; 1999 Sep; 22(9):1265-70. PubMed ID: 10454724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]